BioPorto (CO:BIOPOR) — Stock Price
BioPorto (CO:BIOPOR) is currently trading at Dkr1.13 DKK, down 2.59% today. Over the past 52 weeks, shares have ranged between Dkr0.84 and Dkr1.44. This page tracks BioPorto's live share price on the CO exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market cap of BioPorto.
BioPorto (BIOPOR) Stock Price Chart — Daily History & Trading Volume
The chart below tracks BioPorto's daily closing share price and trading volume on the CO exchange over the past year, giving a clear view of recent price momentum and liquidity.
BioPorto Income Statement — Revenue, Profit & Earnings by Year
BioPorto's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | Dkr40.29 Million | Dkr36.24 Million | Dkr30.96 Million | Dkr28.97 Million | Dkr24.25 Million |
| Cost of Revenue | Dkr12.27 Million | Dkr11.71 Million | Dkr10.78 Million | Dkr9.93 Million | Dkr9.21 Million |
| Gross Profit | Dkr28.01 Million | Dkr24.53 Million | Dkr20.18 Million | Dkr19.04 Million | Dkr15.04 Million |
| Research & Development | Dkr50.07 Million | Dkr33.53 Million | Dkr25.45 Million | Dkr34.94 Million | Dkr30.26 Million |
| SG&A | Dkr64.04 Million | Dkr36.25 Million | Dkr36.03 Million | Dkr41.83 Million | Dkr32.66 Million |
| Total Operating Expenses | Dkr114.11 Million | Dkr99.98 Million | Dkr81.35 Million | Dkr97.99 Million | Dkr80.30 Million |
| Operating Income | Dkr-86.09 Million | Dkr-75.45 Million | Dkr-60.16 Million | Dkr-77.88 Million | Dkr-65.25 Million |
| EBITDA | Dkr-83.59 Million | Dkr-70.53 Million | Dkr-57.89 Million | Dkr-76.49 Million | Dkr-58.47 Million |
| EBIT | Dkr-86.09 Million | Dkr-72.91 Million | Dkr-60.56 Million | Dkr-80.46 Million | Dkr-62.79 Million |
| Interest Expense | Dkr772.00K | Dkr834.00K | Dkr642.00K | Dkr1.21 Million | Dkr912.00K |
| Income Before Tax | Dkr-87.64 Million | Dkr-73.74 Million | Dkr-61.21 Million | Dkr-81.55 Million | Dkr-63.84 Million |
| Income Tax Expense | Dkr-5.52 Million | Dkr-5.50 Million | Dkr-4.88 Million | Dkr-5.62 Million | Dkr-6.73 Million |
| Net Income | Dkr-82.12 Million | Dkr-68.24 Million | Dkr-56.33 Million | Dkr-75.92 Million | Dkr-57.11 Million |
BioPorto Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes BioPorto's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | Dkr93.18 Million | Dkr96.01 Million | Dkr89.81 Million | Dkr108.64 Million | Dkr81.25 Million |
| Total Current Assets | Dkr84.96 Million | Dkr83.90 Million | Dkr82.28 Million | Dkr101.43 Million | Dkr64.20 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | Dkr18.52 Million | Dkr9.55 Million | Dkr3.31 Million | Dkr4.60 Million | Dkr7.92 Million |
| Inventory | Dkr9.25 Million | Dkr4.64 Million | Dkr3.79 Million | Dkr2.56 Million | Dkr2.72 Million |
| Property, Plant & Equipment | — | — | — | Dkr4.51 Million | Dkr14.27 Million |
| Goodwill | — | — | — | — | — |
| Total Liabilities | Dkr30.17 Million | Dkr28.23 Million | Dkr29.65 Million | Dkr38.42 Million | Dkr35.29 Million |
| Total Current Liabilities | Dkr26.12 Million | Dkr20.39 Million | Dkr25.37 Million | Dkr30.97 Million | Dkr24.79 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | Dkr-47.37 Million | Dkr-48.47 Million | Dkr-59.15 Million | Dkr-71.15 Million | Dkr-32.49 Million |
| Total Stockholder Equity | Dkr63.01 Million | Dkr67.78 Million | Dkr60.16 Million | Dkr70.22 Million | Dkr45.96 Million |
| Retained Earnings | Dkr-433.32 Million | Dkr-360.84 Million | Dkr-319.74 Million | Dkr-264.24 Million | Dkr-221.67 Million |
BioPorto Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how BioPorto generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | Dkr-77.07 Million | Dkr-83.58 Million | Dkr-55.46 Million | Dkr-52.48 Million | Dkr-64.58 Million |
| Capital Expenditures | Dkr0.00 | Dkr350.00K | Dkr39.00K | Dkr471.00K | Dkr389.00K |
| Free Cash Flow | Dkr-77.07 Million | Dkr-83.93 Million | Dkr-55.49 Million | Dkr-52.96 Million | Dkr-64.97 Million |
| Investing Cash Flow | Dkr1.27 Million | Dkr1.19 Million | Dkr-277.00K | Dkr-503.00K | Dkr-412.00K |
| Financing Cash Flow | Dkr71.94 Million | Dkr75.47 Million | Dkr40.79 Million | Dkr88.70 Million | Dkr1.10 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | Dkr-637.00K | Dkr-875.00K | Dkr1.38 Million | Dkr7.56 Million | Dkr-966.00K |
| Depreciation | Dkr2.51 Million | Dkr2.38 Million | Dkr2.68 Million | Dkr3.97 Million | Dkr4.33 Million |
| Change in Cash | Dkr-4.77 Million | Dkr-6.74 Million | Dkr-15.39 Million | Dkr36.27 Million | Dkr-62.42 Million |
BioPorto Earnings History — EPS Actual vs. Analyst Estimates
Track BioPorto's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 06, 2026 | — | — | — |
| Mar 26, 2026 | -0.03 | — | — |
| Nov 20, 2025 | -0.05 | — | — |
| Aug 15, 2025 | -0.04 | -0.05 | +20.00% |
| May 08, 2025 | -0.06 | -0.05 | -20.00% |
| Mar 20, 2025 | -0.04 | -0.03 | -33.33% |
| Nov 14, 2024 | -0.05 | -0.05 | +0.00% |
| Aug 15, 2024 | -0.04 | -0.03 | -33.33% |